LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced that it has been granted a key patent by the European Patent Office (EPO) for the company’s personalized blood glucose monitoring device. The patent, EP2569622, entitled “FLUID TESTING APPARATUS AND METHODS OF USE,” covers claims related to a method and apparatus for performing fluid parameter measurement on a fluid sample via an earphone socket on a mobile phone. The EPO decision to grant was reached on April 7, 2016, and the patent became effective on May 4, 2016.
The Dario smart glucose monitoring device is designed to work in tandem with LabStyle’s novel and powerful Dario™ software application to form the overall Dario™ Diabetes Management Tool.
“This patent is a key addition to the LabStyle Innovations Intellectual Property portfolio. It represents another important milestone for the Company and validates the unique and proprietary technology that forms the basis of the Dario Diabetes Management Tool,” stated Erez Raphael, LabStyle’s President and Chief Executive Officer. “The granted patent with the allowed claims underscores our ownership of this technology and covers our methodology that has been based upon our extensive database of reference feedback, close customer collaboration, and innovative product engineering and development.”
About LabStyle Innovations
LabStyle Innovations Corp. (NASDAQ: DRIO) creates innovative mobile and digital tools that empower and engage users to lead healthier lives. LabStyle’s “Real data. Real time. Real improvements.“ approach and strategy is positioning the company as a major player in the mHealth industry; an industry currently worth $10B and expected to reach $31B by 2020. LabStyle’s flagship product, The Dario™ Smart Diabetes Management Solution, is a platform for diabetes management that combines an all-in-one blood glucose meter, native smart phone app (iOS & Android), website portal and a wide variety of treatment tools to support more proactive and better informed decisions by users living with diabetes, their doctors and healthcare systems.